Abstract
Increased intracranial pressure (ICP) following acute brain injury requires the accumulation of additional water in the intracranial vault. One source of such water is the vasculature, although the mechanisms associated with control of blood–brain barrier permeability are unclear. We have recently shown that acute brain injury, such as neurotrauma and stroke, results in perivascular accumulation of the neuropeptide, substance P. This accumulation is associated with increased blood–brain barrier permeability and formation of vasogenic edema. Administration of a substance P antagonist targeting the tachykinin NK1 receptor profoundly reduced the increased blood–brain barrier permeability and edema formation, and in small animal models of acute brain injury, improved functional outcome. In a large, ovine model of experimental traumatic brain injury, trauma resulted in a significant increase in ICP. Administration of an NK1 antagonist caused a profound reduction in post-traumatic ICP, with levels returning to normal within 4 h of drug administration. Substance P NK1 antagonists offer a novel therapeutic approach to the treatment of acute brain injury.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vink R, Nimmo AJ (2009) Multifunctional drugs for head injury. Neurotherapeutics 6:28–42
Feickert HJ, Drommer S, Heyer R (1999) Severe head injury in children: impact of risk factors on outcome. J Trauma 47:33–38
Marmarou A (2003) Pathophysiology of traumatic brain edema: current concepts. Acta Neurochir Suppl 86:7–10
American Association of Neurological Surgeons (2000) The joint section on neurotrauma and critical care: initial management. J Neurotrauma 17:463–469
Marmarou A (2007) A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg Focus 22:E1
Brain SD, Williams TJ (1989) Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br J Pharmacol 97:77–82
Baluk P (1997) Neurogenic inflammation in skin and airways. J Investig Dermatol Symp Proc 2:76–81
Bost KL (2004) Tachykinin-mediated modulation of the immune response. Front Biosci 9:3331–3332
Donkin JJ, Nimmo AJ, Cernak I, Blumbergs PC, Vink R (2009) Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury. J Cereb Blood Flow Metab 29:1388–1398
Cook NL, Vink R, Donkin JJ, van den Heuvel C (2009) Validation of reference genes for normalization of real-time quantitative RT-PCR data in traumatic brain injury. J Neurosci Res 87:34–41
Turner RJ, Blumbergs PC, Sims NR, Helps SC, Rodgers KM, Vink R (2006) Increased substance P immunoreactivity and edema formation following reversible ischemic stroke. Acta Neurochir Suppl 96:263–266
Zacest AC, Vink R, Manavis J, Sarvestani GT, Blumbergs PC (2010) Substance P immunoreactivity increases following human traumatic brain injury. Acta Neurochir Suppl 106:211–216
Harford-Wright E, Thornton E, Vink R (2010) Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury. Neurosci Lett 481:26–29
Nimmo AJ, Cernak I, Heath DL, Hu X, Bennett CJ, Vink R (2004) Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides 38:40–47
Turner RJ, Helps SC, Thornton E, Vink R (2011) A substance P antagonist improves outcome when administered 4 h after onset of ischemic stroke. Brain Res 1393:84–90
Donkin JJ, Cernak I, Blumberg PC, Vink R (2011) A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury. J Neurotrauma 28:218–224
Gabrielian L, Willshire LW, Helps SC, van den Heuvel C, Mathias JL, Vink R (2011) Intracranial pressure changes following traumatic brain injury in rats: lack of significant change in the absence of mass lesions or hypoxia. J Neurotrauma 28:2103–2111
Vink R, Bhatia KD, Reilly PL (2008) The relationship between intracranial pressure and brain oxygenation following traumatic brain injury in sheep. Acta Neurochir Suppl 102:189–192
Byard RW, Bhatia KD, Reilly PL, Vink R (2009) How rapidly does cerebral swelling follow trauma? Observations using an animal model and possible implications in infancy. Leg Med (Tokyo) 11(Suppl 1):S128–S131
Acknowledgment
Supported, in part, by the National Health and Medical Research Council (Australia) and the Neurosurgical Research Foundation.
Conflict of InterestWe declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this paper
Cite this paper
Gabrielian, L., Helps, S.C., Thornton, E., Turner, R.J., Leonard, A.V., Vink, R. (2013). Substance P Antagonists as a Novel Intervention for Brain Edema and Raised Intracranial Pressure. In: Katayama, Y., Maeda, T., Kuroiwa, T. (eds) Brain Edema XV. Acta Neurochirurgica Supplement, vol 118. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1434-6_37
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1434-6_37
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1433-9
Online ISBN: 978-3-7091-1434-6
eBook Packages: MedicineMedicine (R0)